Advertisement
Canada markets closed

  • S&P/TSX

    24,471.17
    +168.91 (+0.70%)
     

  • S&P 500

    5,815.03
    +34.98 (+0.61%)
     

  • DOW

    42,863.86
    +409.74 (+0.97%)
     

  • CAD/USD

    0.7266
    -0.0011 (-0.16%)
     

  • CRUDE OIL

    75.49
    -0.36 (-0.47%)
     

  • Bitcoin CAD

    86,123.52
    -506.70 (-0.58%)
     

  • XRP CAD

    0.73
    -0.01 (-1.44%)
     

  • GOLD FUTURES

    2,674.20
    +34.90 (+1.32%)
     

  • RUSSELL 2000

    2,234.41
    +45.99 (+2.10%)
     

  • 10-Yr Bond

    4.0730
    -0.0230 (-0.56%)
     

  • NASDAQ

    18,342.94
    +60.89 (+0.33%)
     

  • VOLATILITY

    20.46
    -0.47 (-2.25%)
     

  • FTSE

    8,253.65
    +15.92 (+0.19%)
     

  • NIKKEI 225

    39,605.80
    +224.91 (+0.57%)
     

  • CAD/EUR

    0.6642
    -0.0011 (-0.17%)
     

How Abbott Labs Is Leaning Into Obesity Treatment, And Taking On Dexcom

ALLISON GATLIN
·3 min read
How Abbott Labs Is Leaning Into Obesity Treatment, And Taking On Dexcom

Abbott Laboratories launched its newest CGM in the U.S. on Thursday. The biosensor named Lingo is the first-ever for people without diabetes.

Continue reading